The role of bcl-2 in the progression of the colorectal adenoma-carcinoma sequence

Anticancer Research

Volumn 19, Issue 1 B, 1999, Pages 727-730

  Yang, Hsiao Bai ^a   Chow, Nan Haw ^a   Sheu, Bor Shyang ^a   Chan, Shih Huang ^b   Chien, Chung Ho ^a   Su, Ih Jen ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Adenoma carcinoma sequence; BCL 2; Colorectum; Growth control

Indexed keywords

PROTEIN BCL 2;

ADENOCARCINOMA; ADULT; ARTICLE; COLON MUCOSA; COLORECTAL CARCINOMA; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE;

ADENOCARCINOMA; ADENOMA; ADULT; COLON; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0032928815     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Muto T, Bussey HJR, Morson BC: The evolution of cancer of the colon and rectum. Cancer 36: 2251-70, 1975.
2. Vogelstein B, Fearon ER, Hamilton SR, et al: Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-32, 1988.
3. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-67, 1990.
4. Deschner EE, Lipkin M, Solomon C: In Vitro study of human epithelial cells. II: H3 thymidine incorporation into polyps and adjacent mucosa. J Natl Cancer Inst 36: 849-57, 1966.
5. Risio M, Coverlizza S, Ferrari A, Candelaresi GL, Rossini FP: Immunohistochemical study of epithelial cell proliferation in hyperplastic polyps, adenomas and adenocarcinomas of the large bowel. Gastroenterology 94: 899-906, 1988.
6. Kimura H, Kanno M, Takamura H, et al: Histopathologic and flow cytometric analysis of colorectal polyps resected at endoscopy. Eur Surg Res 25: 187-92, 1993.
7. Risio M, Candelaresi G, Rossini FP: Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence. Cancer Epidem Biomar 2: 363-7, 1993.
8. Yang HB, Hsu PI, Chan SH, Shin JS, Chow NH: Growth kinetics of colorectal adenoma-carcinoma sequence. An immunohistochemical study of proliferating cell nuclear antigen expression. Hum Pathol 27: 1071-6, 1996.
9. Kernohan NM, Cox LS: Regulation of apoptosis by Bcl-2 and its related proteins: immunochemical challenges and therapeutic implications. J Pathol 179: 1-3, 1996.
10. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM: Cloning of the chromosome breakpoint of neoplastic B cells with the t(14: 18) chromosome translocation. Science 226: 1097-9, 1984.
11. Boise LH, Gonzalez-Garcia M, Postema CE. et al: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608, 1993.
12. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-19, 1993
13. Stewart BW. Mechanisms of apoptosis: Integration of genetic, biochemical, and cellular indicators. J Natl Cancer Inst 86: 1286-96, 1994.
14. Hockenbery D, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: BCL-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88: 6961-5, 1991.
15. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
16. Baretton GB, Diebold J, Christoforis G, et al: Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Cancer 77: 255-64, 1996.
17. Merritt AJ, Potten CS, Watson AJ, et al: Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Sci 108: 2261-71, 1995.
18. Gottschalk AR, Boise LH, Thompson CB, Quintans J: Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2. Proc Natl Acad Sci USA 91: 7350-54, 1994.
19. Bronner MP, Culin C, Reed JC, Furth EE: The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol 146: 20-26, 1995.
20. Bosari S, Moneghini L, Graziani D, et al: bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas and adenocarcinomas. Hum Pathol 26: 534-40, 1995.
21. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B: Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55: 237-41, 1995.
22. Lu QL, Poulsom R, Wong L, Hanby A: Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 169: 431-37, 1993.
23. Hague A, Moorghen M, Hicks D, Chapman M, Paraskeva C: BCL-2 expression in human colorectal adenomas and carcinomas. Oncogene 9: 3367-70, 1994.
24. Watson AJ, Merritt AJ, Jones LS, et al: Evidence for reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas. Brit J Cancer 73: 889-95, 1996.
25. Jass JR, Sobin LH: Histological typing of intestinal tumours. World Health Organization. International Classification of Tumours. New York: Springer, 1989.
26. Nunez, G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ: Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144: 3602-10, 1990.
27. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-6, 1990.
28. Cotter TG, Lennon SV, Glynn JG, Martin SJ: Cell death via apoptosis and its relationship to growth, development and differentiation of both tumour and normal cells. Anticancer Res 10: 1153-9, 1990.
29. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80: 879-86, 1992.
30. Saegusa M, Takano Y, Hashimura M, Shoji Y, Okayasu I: The possible role of bcl-2 expression in the progression of tumors of the uterine cervix. Cancer 76: 2297-303, 1995.
31. Nakamura T, Nomura S, Sakai T, Nariya S: Expression of bcl-2 oncoprotein in gastrointestinal and uterine carcinomas and their premalignant lesions. Hum Pathol 28: 309-15, 1997.
32. Magrisso IJ, Richmond RE, Carter JH, Pross CB, Gilfillen RA, Carter HW: Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas. Lab Invest 69: 674-81, 1993.
33. Ohue M, Tomita N, Monden T, et al: A frequent alteration of p53 gene in carcinoma in adenoma of colon. Cancer Res 54: 4798-804, 1994
34. Yamaguchi A, Makimoto K, Goi T, et al: Overexpression of p53 protein and proliferative activity in colorectal adenoma. Oncology 51: 224-7, 1994.
35. Pavelic ZP, Pavelic L, Kuvelkar R, Gapany SR: High c-myc protein expression in benign colorectal lesions correlates with the degree of dysplasia. Anticancer Res 12: 171-5, 1992.